Simvastatin-induced rhabdomyolysis: a case study on clinical-decision making based on the evidence-based medicine approach
Journal Title: Archives of Medical Science - Year 2007, Vol 3, Issue 3
Abstract
A case of a woman diagnosed to have rhabdomyolysis is presented. It was attributed to simvastatin she had been receiving for 1 year. Based on pathogenesis and medical examination, the diagnosis of statin-induced rhabdomyolysis was made. Simvastatin was discontinued with concomitant clinical improvement followed by serum creatine kinase decrease. Future course of therapy was decided after reviewing the literature using evidence-based medicine tools. The purpose of this case report is to share our experience so that physicians are reminded of the potential of rhabdomyolysis related to statin use and illustrate the value of evidence-based medicine in clinical practice.
Authors and Affiliations
Konstantinos Koskinas, Thrasyvoulos Tzellos, Kyriakos Gougoulias, Georgios Gougoulias, Christos Papakonstantinou, Dimitrios Kouvelas
Estimation of cardiovascular complications and death risk in subjects with metabolic syndrome
Introduction: Coexistence of lipid and carbohydrate disorders with hypertension and obesity increases the risk of ischaemic heart disease and its complications. The recently observed lack of reduction in the incidence...
Anomalous superficial palmar arch: a cadaveric study with clinical implications
Sudden infant death syndrome, prematurity and sleeping position
Sudden infant death syndrome (SIDS), an unexpected death of an infant which remains unexplained after a thorough investigation, is the commonest cause of postneonatal mortality in the developed world. Prematurely born in...
Glial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase
Diagnosis and treatment of chronic lymphocytic leukaemia: practical remarks